JapanStake
Wholesale Trade · Fiscal year end Sep 30

TOHOKU CHEMICAL CO., LTD.

7446

東北化学薬品株式会社

FIGI BBG000F5P2187446.T7446 JPCorp. no. 5420001009282

Latest half-year results

First half · fiscal year to 2026-09 · filed 2026-05-14

For the first half of the fiscal year to 2026-09: Revenue ¥18.9 billion (+6.4% YoY), Ordinary income ¥0.6 billion (+59.0% YoY), Net income ¥0.4 billion (+47.3% YoY).

This periodYear on year
Revenue¥18.9bn+6.4%
Ordinary profit¥565m+59.0%
Net profit to owners¥396m+47.3%

From the securities report on EDINET, which states no forecast. History via /v1/companies/7446/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-09-30
Revenue
¥34.4bn
Net income
¥429m
ROE
5.6%
Equity ratio
43.0%
Dividend / share
¥125
Employees
315
Revenue · ¥bn
FY2021: ¥36.2bn 36.2 FY2021FY2022: ¥37.3bn 37.3 FY2022FY2023: ¥35.1bn 35.1 FY2023FY2024: ¥32.2bn 32.2 FY2024FY2025: ¥34.4bn 34.4 FY2025
Net income · ¥m
FY2021: ¥517m 517 FY2021FY2022: ¥658m 658 FY2022FY2023: ¥556m 556 FY2023FY2024: ¥237m 237 FY2024FY2025: ¥429m 429 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-09-30¥34.4bn¥0.4bn¥18.4bn¥8.0bn5.6%¥475.93¥0.1bn
2024-09-30¥32.2bn¥0.2bn¥17.2bn¥7.5bn3.3%¥263.54−¥1.0bn
2023-09-30¥35.1bn¥0.6bn¥18.9bn¥7.3bn8.1%¥617.29¥1.3bn
2022-09-30¥37.3bn¥0.7bn¥17.5bn¥6.7bn10.2%¥728.76¥0.9bn
2021-09-30¥36.2bn¥0.5bn¥16.1bn¥6.3bn8.7%¥564.91¥0.3bn

Indicators

Computed by us from filings · fiscal year to 2025-09-30
MetricValuePercentile among listed companies
ROE, %5.628.8
Ordinary margin0.017315.8
Equity ratio, %4331.3
Revenue growth0.071159.8
Net income growth0.805882.3
Operating cash flow / assets0.008118.8
Policy-uncertainty measure1.20 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 13.2% held by other listed companies.

Results wording balance: +0.86. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥351m of reported debt repriced by 50 basis points, a year's interest would rise by ¥2m, 1.2% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/7446/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2025-12-17: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Industry Sales Group, Medical Sales Group, Academia Life Science Sales Group. /v1/companies/7446/segments
Latest voting result: 2025-12-18 · 剰余金処分の件 · passed. /v1/companies/7446/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥3,395¥3,695¥3,995 2021-06-142024-04-15 2024-04-15 · bought 400 @ ¥3,990 · individual filer2024-02-16 · bought 700 @ ¥3,995 · individual filer2021-08-12 · bought 200 @ ¥3,595 · individual filer2021-07-14 · bought 200 @ ¥3,595 · individual filer2021-06-14 · bought 200 @ ¥3,395 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
株式会社みちのく銀行2025-01-01 – 2025-01-0100.00pt——
株式会社青森みちのく銀行2025-01-01 – 2025-01-0100.00pt——
individual filer2021-06-14 – 2024-04-15+1,700+0.17pt¥3,829.12¥3,395–3,995
individual filer2017-08-09 – 2022-08-0800.00pt——
株式会社みちのく銀行2022-03-01 – 2022-03-09-1,000−0.10pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/7446/trades.

5% filings

Large shareholding reports on 7446
FiledFilerStakeChangeStated purpose
2025-09-10individual filer6.58%−1.21pt—
2025-09-10individual filer5.42%−1.16pt—
2025-09-10individual filer7.05%+1.01pt—
2025-09-10individual filer8.05%+1.00pt—
2025-01-24Aomori Michinoku Bank, Ltd.9.33%−0.05ptstrategic holding
2025-01-09Aomori Michinoku Bank, Ltd.9.33%−0.05ptstrategic holding
2022-04-01Procrea Holdings, Inc.9.38%—strategic holding

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
24 issues
Book value
¥1.9bn
Sold in the year
— — issues
Bought in the year
¥40m 10 issues
Mutual, both reports
4
Held by listed cos.
5
HoldsBook valueShares vs. prior yearMutual
Nippon Soda Co.,Ltd. 4041¥336m+2.4%both reports
Mitsubishi Corporation 8058¥222m0.0%no
HORIBA, Ltd. 6856¥212m+2.8%no
ESPEC CORP. 6859¥171m+3.6%no
JEOL Ltd. 6951¥152m0.0%both reports
SYSMEX CORPORATION 6869¥131m0.0%stated
Central Glass Co.,Ltd. 4044¥129m+4.4%no
Meiji Holdings Co., Ltd. 2269¥129m+4.1%no
DOWA HOLDINGS CO.,LTD. 5714¥88m+4.2%no
TOSOH CORPORATION 4042¥82m+5.7%both reports

Held by: Procrea Holdings, Inc. 7384, Nippon Soda Co.,Ltd. 4041, TOSOH CORPORATION 4042, GLTECHNO HOLDINGS, INC. 255A, JEOL Ltd. 6951

Purposes, all holdings and mutual flags via /v1/companies/7446/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-09-30
ShareholderSharesRatio
㈱青森みちのく銀行89,6009.90%
東北化学薬品取引先持株会82,3009.10%
東北化学薬品従業員持株会51,9405.80%
東京中小企業投資育成㈱50,8005.60%
individual holder41,0604.60%
individual holder32,2003.60%
individual holder30,2003.40%
individual holder22,0002.40%
individual holder20,4002.30%
individual holder19,7902.20%

Get this as JSON

GET /v1/companies/7446
GET /v1/companies/7446/financials
GET /v1/companies/7446/details
GET /v1/companies/7446/segments
GET /v1/companies/7446/voting
GET /v1/companies/7446/tender-offers
GET /v1/companies/7446/indicators
GET /v1/companies/7446/earnings-releases
GET /v1/events?ticker=7446
GET /v1/companies/7446/trades         
GET /v1/companies/7446/cross-holdings 
GET /v1/companies/7446/brief

Plans from $9 a month · Documentation